{"nctId":"NCT00547248","briefTitle":"Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines","startDateStruct":{"date":"2007-10-22","type":"ACTUAL"},"conditions":["Infections, Streptococcal"],"count":756,"armGroups":[{"label":"Synflorix + Tritanrix -HepB/ Hiberix + Polio Sabin Group","type":"EXPERIMENTAL","interventionNames":["Biological: Synflorix","Biological: Tritanrix-HepB","Biological: Hiberix","Biological: Polio Sabin"]},{"label":"Prevenar + Tritanrix - HepB/ Hiberix + Polio Sabin Group","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: Tritanrix-HepB","Biological: Hiberix","Biological: Polio Sabin","Biological: Prevenar (Wyeth)"]},{"label":"Synflorix + Tritanrix -HepB/ Hiberix + Poliorix Group","type":"EXPERIMENTAL","interventionNames":["Biological: Synflorix","Biological: Tritanrix-HepB","Biological: Hiberix","Biological: Poliorix"]},{"label":"Prevenar + Tritanrix -HepB/ Hiberix + Poliorix Group","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: Tritanrix-HepB","Biological: Hiberix","Biological: Poliorix","Biological: Prevenar (Wyeth)"]}],"interventions":[{"name":"Synflorix","otherNames":["Pneumococcal conjugate vaccine GSK1024850A"]},{"name":"Tritanrix-HepB","otherNames":["DTPw-HBV vaccine"]},{"name":"Hiberix","otherNames":["Hib vaccine"]},{"name":"Polio Sabin","otherNames":["OPV"]},{"name":"Poliorix","otherNames":["IPV"]},{"name":"Prevenar (Wyeth)","otherNames":["Pneumococcal conjugate vaccine"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects for whom the investigator believes that their parents/guardians can and will comply with the requirements of the protocol.\n* A male or female between, and including, 12-18 months of age at the time of the booster vaccination and who previously participated in study 107007 and received three doses of pneumococcal conjugate vaccine.\n* Written informed consent obtained from the parent or guardian of the subject.\n* Free of obvious health problems as established by medical history and clinical examination before entering into the study.\n\nExclusion Criteria:\n\n* Concurrently participating in another clinical study, at any time during the study period (active phase and extended safety follow-up), in which the subject has been or will be exposed to an investigational or a non-investigational product (pharmaceutical product or device).\n* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccines within one month preceding the booster dose of study vaccines, or planned use during the entire study period\n* Chronic administration (defined as more than 14 days) of immunosuppressants or other immune-modifying drugs within 6 months prior to the booster dose of study vaccines.\n* Planned administration/administration of a vaccine not foreseen by the study protocol, during the period starting one month before the booster dose of study vaccines and up to the follow-up visit.\n* Administration of any pneumococcal, diphtheria, tetanus, pertussis, polio, hepatitis B, Haemophilus influenzae type b vaccine other than the study vaccines from study 107007.\n* History of, or intercurrent diphtheria, tetanus, pertussis, polio, hepatitis B, Haemophilus influenzae type b diseases.\n* History of allergic disease or reactions likely to be exacerbated by any component of the vaccines.\n* History of seizures (this criterion does not apply to subjects who have had a single, uncomplicated febrile convulsion in the past) or progressive neurological disease.\n* Acute disease at the time of enrolment.\n* Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination\n* A family history of congenital or hereditary immunodeficiency.\n* Major congenital defects or serious chronic illness.\n* Administration of immunoglobulins and/or any blood products within three months preceding the booster dose of study vaccines or planned administration during the active phase of the study.","healthyVolunteers":true,"sex":"ALL","minimumAge":"12 Months","maximumAge":"18 Months","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects Reporting Rectal Temperature Greater Than (>) the Cut-off","description":"Fever was measured as rectal temperature. The cut-off was 39.0 degree Celsius (°C). Assessment of occurrences of fever \\> 39.0 (°C) was performed after booster vaccination with Synflorix™ or Prevenar™ vaccines.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64","spread":null},{"groupId":"OG001","value":"20","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Grade 3 Solicited Local Symptoms","description":"Solicited local symptoms assessed included pain, redness and swelling. \"Any\" was defined as incidence of the specified symptom regardless of intensity. Grade 3 pain was defined as crying when limb was moved/ spontaneously painful. Grade 3 swelling/ redness was defined as swelling/ redness greater than (\\>) 30 millimeters (mm).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"203","spread":null},{"groupId":"OG001","value":"66","spread":null},{"groupId":"OG002","value":"248","spread":null},{"groupId":"OG003","value":"77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"20","spread":null},{"groupId":"OG002","value":"117","spread":null},{"groupId":"OG003","value":"39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"107","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"197","spread":null},{"groupId":"OG003","value":"66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"35","spread":null},{"groupId":"OG003","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null},{"groupId":"OG001","value":"32","spread":null},{"groupId":"OG002","value":"158","spread":null},{"groupId":"OG003","value":"52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"9","spread":null},{"groupId":"OG002","value":"34","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Grade 3 Solicited General Symptoms","description":"Solicited general symptoms assessed include drowsiness, fever (defined as rectal temperature greater than or equal to (≥) 38.0°C), irritability, and loss of appetite.\"Any\" was defined as incidence of the specified symptom regardless of intensity or relationship to study vaccination. Grade 3 drowsiness was defined as drowsiness which prevented normal everyday activities. Grade 3 fever was defined as fever (rectal temperature) \\>40.0 degree Celsius (°C). Grade 3 irritability was defined as crying that could not be comforted/ preventing normal activity. Grade 3 loss of appetite was defined as the subject not eating at all.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null},{"groupId":"OG001","value":"32","spread":null},{"groupId":"OG002","value":"190","spread":null},{"groupId":"OG003","value":"66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"138","spread":null},{"groupId":"OG001","value":"51","spread":null},{"groupId":"OG002","value":"215","spread":null},{"groupId":"OG003","value":"65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"173","spread":null},{"groupId":"OG001","value":"64","spread":null},{"groupId":"OG002","value":"243","spread":null},{"groupId":"OG003","value":"79","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"40","spread":null},{"groupId":"OG003","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97","spread":null},{"groupId":"OG001","value":"28","spread":null},{"groupId":"OG002","value":"184","spread":null},{"groupId":"OG003","value":"57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"13","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Unsolicited Adverse Events (AEs)","description":"An AE is any untoward medical occurrence in a clinical investigation subject, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. \"Any\" was defined an incidence of an unsolicited AE regardless of intensity or relationship to study vaccination.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"9","spread":null},{"groupId":"OG002","value":"106","spread":null},{"groupId":"OG003","value":"35","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Serious Adverse Events (SAEs)","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/ incapacity.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"5","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-pneumococcal Serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F Antibody Concentrations ≥ the Cut-off","description":"The cut-off was 0.20 microgram per milliliter (μg/mL).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"64","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"78","spread":null},{"groupId":"OG003","value":"23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"98","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"8","spread":null},{"groupId":"OG002","value":"124","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null},{"groupId":"OG001","value":"24","spread":null},{"groupId":"OG002","value":"90","spread":null},{"groupId":"OG003","value":"27","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"122","spread":null},{"groupId":"OG003","value":"41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"128","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"118","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"9","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"132","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"116","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"126","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"111","spread":null},{"groupId":"OG003","value":"40","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130","spread":null},{"groupId":"OG001","value":"36","spread":null},{"groupId":"OG002","value":"111","spread":null},{"groupId":"OG003","value":"35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"129","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"121","spread":null},{"groupId":"OG003","value":"22","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"123","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123","spread":null},{"groupId":"OG001","value":"32","spread":null},{"groupId":"OG002","value":"89","spread":null},{"groupId":"OG003","value":"40","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"123","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]}]},{"type":"SECONDARY","title":"Anti-pneumococcal Serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F Antibody Concentrations","description":"Seropositivity status, defined as anti-pneumococcal serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F antibody concentrations ≥ 0.05 microgram per milliliter (μg/mL).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.35","spread":null},{"groupId":"OG001","value":"0.03","spread":null},{"groupId":"OG002","value":"0.19","spread":null},{"groupId":"OG003","value":"0.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.8","spread":null},{"groupId":"OG001","value":"0.04","spread":null},{"groupId":"OG002","value":"2.14","spread":null},{"groupId":"OG003","value":"0.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.55","spread":null},{"groupId":"OG001","value":"0.34","spread":null},{"groupId":"OG002","value":"0.27","spread":null},{"groupId":"OG003","value":"0.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.16","spread":null},{"groupId":"OG001","value":"11.84","spread":null},{"groupId":"OG002","value":"4.21","spread":null},{"groupId":"OG003","value":"6.86","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.55","spread":null},{"groupId":"OG001","value":"0.06","spread":null},{"groupId":"OG002","value":"0.4","spread":null},{"groupId":"OG003","value":"0.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.59","spread":null},{"groupId":"OG001","value":"0.09","spread":null},{"groupId":"OG002","value":"2.54","spread":null},{"groupId":"OG003","value":"0.05","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.66","spread":null},{"groupId":"OG001","value":"0.38","spread":null},{"groupId":"OG002","value":"0.34","spread":null},{"groupId":"OG003","value":"0.34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.02","spread":null},{"groupId":"OG001","value":"9.08","spread":null},{"groupId":"OG002","value":"2.31","spread":null},{"groupId":"OG003","value":"6.28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":null},{"groupId":"OG001","value":"0.05","spread":null},{"groupId":"OG002","value":"0.58","spread":null},{"groupId":"OG003","value":"0.03","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.52","spread":null},{"groupId":"OG001","value":"0.06","spread":null},{"groupId":"OG002","value":"4.14","spread":null},{"groupId":"OG003","value":"0.03","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.16","spread":null},{"groupId":"OG001","value":"0.77","spread":null},{"groupId":"OG002","value":"0.59","spread":null},{"groupId":"OG003","value":"0.58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.42","spread":null},{"groupId":"OG001","value":"20.31","spread":null},{"groupId":"OG002","value":"4.63","spread":null},{"groupId":"OG003","value":"13.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.32","spread":null},{"groupId":"OG001","value":"1.83","spread":null},{"groupId":"OG002","value":"0.84","spread":null},{"groupId":"OG003","value":"1.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.07","spread":null},{"groupId":"OG001","value":"27.42","spread":null},{"groupId":"OG002","value":"5.93","spread":null},{"groupId":"OG003","value":"15.51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.43","spread":null},{"groupId":"OG001","value":"0.42","spread":null},{"groupId":"OG002","value":"0.63","spread":null},{"groupId":"OG003","value":"0.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.59","spread":null},{"groupId":"OG001","value":"12.07","spread":null},{"groupId":"OG002","value":"10.49","spread":null},{"groupId":"OG003","value":"9.92","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.33","spread":null},{"groupId":"OG001","value":"0.16","spread":null},{"groupId":"OG002","value":"0.99","spread":null},{"groupId":"OG003","value":"0.35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.25","spread":null},{"groupId":"OG001","value":"6.61","spread":null},{"groupId":"OG002","value":"12.23","spread":null},{"groupId":"OG003","value":"6.01","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.94","spread":null},{"groupId":"OG001","value":"0.41","spread":null},{"groupId":"OG002","value":"0.33","spread":null},{"groupId":"OG003","value":"0.62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.47","spread":null},{"groupId":"OG001","value":"14.78","spread":null},{"groupId":"OG002","value":"3.16","spread":null},{"groupId":"OG003","value":"10.77","spread":null}]}]}]},{"type":"SECONDARY","title":"Opsonophagocytic Activity (OPA) Titers Against Pneumococcal Serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F","description":"Seropositivity status, defined as Opsonophagocytic activity against pneumococcal serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F ≥ 8.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.2","spread":null},{"groupId":"OG001","value":"4.6","spread":null},{"groupId":"OG002","value":"8.5","spread":null},{"groupId":"OG003","value":"4.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1571.6","spread":null},{"groupId":"OG001","value":"4.9","spread":null},{"groupId":"OG002","value":"161.4","spread":null},{"groupId":"OG003","value":"5.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.5","spread":null},{"groupId":"OG001","value":"18.5","spread":null},{"groupId":"OG002","value":"12.5","spread":null},{"groupId":"OG003","value":"12.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5035.8","spread":null},{"groupId":"OG001","value":"4783.5","spread":null},{"groupId":"OG002","value":"2498.7","spread":null},{"groupId":"OG003","value":"4812.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.8","spread":null},{"groupId":"OG001","value":"4.2","spread":null},{"groupId":"OG002","value":"10.9","spread":null},{"groupId":"OG003","value":"4.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1135.8","spread":null},{"groupId":"OG001","value":"4.9","spread":null},{"groupId":"OG002","value":"149.1","spread":null},{"groupId":"OG003","value":"4.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97.8","spread":null},{"groupId":"OG001","value":"56.6","spread":null},{"groupId":"OG002","value":"9.9","spread":null},{"groupId":"OG003","value":"23.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2896.8","spread":null},{"groupId":"OG001","value":"9302.7","spread":null},{"groupId":"OG002","value":"405.3","spread":null},{"groupId":"OG003","value":"3547.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2278.4","spread":null},{"groupId":"OG001","value":"378.8","spread":null},{"groupId":"OG002","value":"796.3","spread":null},{"groupId":"OG003","value":"63.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12484","spread":null},{"groupId":"OG001","value":"1407.7","spread":null},{"groupId":"OG002","value":"6436.1","spread":null},{"groupId":"OG003","value":"90.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"788","spread":null},{"groupId":"OG001","value":"666.8","spread":null},{"groupId":"OG002","value":"380.2","spread":null},{"groupId":"OG003","value":"247.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4842","spread":null},{"groupId":"OG001","value":"7387.8","spread":null},{"groupId":"OG002","value":"3499.9","spread":null},{"groupId":"OG003","value":"6881.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"298.4","spread":null},{"groupId":"OG001","value":"337.2","spread":null},{"groupId":"OG002","value":"179.6","spread":null},{"groupId":"OG003","value":"236.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3579.7","spread":null},{"groupId":"OG001","value":"4097.3","spread":null},{"groupId":"OG002","value":"1961.3","spread":null},{"groupId":"OG003","value":"2939.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.8","spread":null},{"groupId":"OG001","value":"4.5","spread":null},{"groupId":"OG002","value":"7.8","spread":null},{"groupId":"OG003","value":"4.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2417.2","spread":null},{"groupId":"OG001","value":"966.5","spread":null},{"groupId":"OG002","value":"694","spread":null},{"groupId":"OG003","value":"612.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58.6","spread":null},{"groupId":"OG001","value":"7.3","spread":null},{"groupId":"OG002","value":"33.3","spread":null},{"groupId":"OG003","value":"11.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2016","spread":null},{"groupId":"OG001","value":"473.2","spread":null},{"groupId":"OG002","value":"1059.8","spread":null},{"groupId":"OG003","value":"471","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"948.9","spread":null},{"groupId":"OG001","value":"661.9","spread":null},{"groupId":"OG002","value":"301.8","spread":null},{"groupId":"OG003","value":"790.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7456.2","spread":null},{"groupId":"OG001","value":"23177.9","spread":null},{"groupId":"OG002","value":"3427.3","spread":null},{"groupId":"OG003","value":"19943.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Antibody Concentrations to Protein D (Anti-PD)","description":"Seropositivity status, defined as anti-PD antibody concentrations ≥100 enzyme-linked immunosorbent assay (ELISA) units per milliliter (EL.U/mL).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"573.1","spread":null},{"groupId":"OG001","value":"136.8","spread":null},{"groupId":"OG002","value":"526.8","spread":null},{"groupId":"OG003","value":"73.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4973.9","spread":null},{"groupId":"OG001","value":"124.1","spread":null},{"groupId":"OG002","value":"2769.6","spread":null},{"groupId":"OG003","value":"91.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Antibody Concentrations Against Pneumococcal Cross-reactive Serotypes 6A and 19A","description":"Seropositivity status, defined as anti-pneumococcal cross-reactive serotypes 6A and 19A antibody concentrations ≥ 0.05 microgram per milliliter (μg/mL).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.46","spread":null},{"groupId":"OG001","value":"0.24","spread":null},{"groupId":"OG002","value":"0.12","spread":null},{"groupId":"OG003","value":"0.13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.07","spread":null},{"groupId":"OG001","value":"4.57","spread":null},{"groupId":"OG002","value":"0.84","spread":null},{"groupId":"OG003","value":"2.54","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.24","spread":null},{"groupId":"OG001","value":"0.08","spread":null},{"groupId":"OG002","value":"0.16","spread":null},{"groupId":"OG003","value":"0.06","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.22","spread":null},{"groupId":"OG001","value":"0.58","spread":null},{"groupId":"OG002","value":"1.75","spread":null},{"groupId":"OG003","value":"0.38","spread":null}]}]}]},{"type":"SECONDARY","title":"Opsonophagocytic Activity (OPA) Against Pneumococcal Cross-reactive Serotypes 6A and 19A","description":"Seropositivity status, defined as Opsonophagocytic activity against pneumococcal cross-reactive serotypes 6A and 19A ≥ 8.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"113.6","spread":null},{"groupId":"OG001","value":"191.4","spread":null},{"groupId":"OG002","value":"46.8","spread":null},{"groupId":"OG003","value":"42.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"882.8","spread":null},{"groupId":"OG001","value":"2563.8","spread":null},{"groupId":"OG002","value":"369.7","spread":null},{"groupId":"OG003","value":"1394.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.3","spread":null},{"groupId":"OG001","value":"5.1","spread":null},{"groupId":"OG002","value":"5.3","spread":null},{"groupId":"OG003","value":"4.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"89.3","spread":null},{"groupId":"OG001","value":"8.7","spread":null},{"groupId":"OG002","value":"70.7","spread":null},{"groupId":"OG003","value":"20.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-pneumococcal Serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F Antibody Concentrations ≥ the Cut-off","description":"The cut-off of the assay was 0.05 μg/mL.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"122","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"126","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"18","spread":null},{"groupId":"OG002","value":"128","spread":null},{"groupId":"OG003","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"31","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"132","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"127","spread":null},{"groupId":"OG003","value":"39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"124","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"13","spread":null},{"groupId":"OG002","value":"130","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"17","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"130","spread":null},{"groupId":"OG003","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"130","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"129","spread":null},{"groupId":"OG003","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"129","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"124","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"132","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"124","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Opsonophagocytic Activity (OPA) Titers Against Pneumococcal Serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F ≥ the Cut-off","description":"The cut-off for the assay was 8.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"61","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"45","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"114","spread":null},{"groupId":"OG003","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":null},{"groupId":"OG001","value":"20","spread":null},{"groupId":"OG002","value":"39","spread":null},{"groupId":"OG003","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"119","spread":null},{"groupId":"OG003","value":"35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"94","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"56","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130","spread":null},{"groupId":"OG001","value":"4","spread":null},{"groupId":"OG002","value":"114","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"93","spread":null},{"groupId":"OG001","value":"21","spread":null},{"groupId":"OG002","value":"34","spread":null},{"groupId":"OG003","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"106","spread":null},{"groupId":"OG003","value":"32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"133","spread":null},{"groupId":"OG001","value":"28","spread":null},{"groupId":"OG002","value":"109","spread":null},{"groupId":"OG003","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"36","spread":null},{"groupId":"OG002","value":"122","spread":null},{"groupId":"OG003","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"121","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"121","spread":null},{"groupId":"OG003","value":"35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"119","spread":null},{"groupId":"OG001","value":"39","spread":null},{"groupId":"OG002","value":"93","spread":null},{"groupId":"OG003","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"132","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"120","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"84","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"42","spread":null},{"groupId":"OG003","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"133","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"114","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"117","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"96","spread":null},{"groupId":"OG003","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"39","spread":null},{"groupId":"OG002","value":"118","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"99","spread":null},{"groupId":"OG003","value":"30","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"120","spread":null},{"groupId":"OG003","value":"37","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Concentrations of Antibodies Against Cross-reactive Pneumococcal Serotypes 6A and 19A ≥ the Cut-off","description":"The cut-of for the assay was 0.05 μg/mL.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"128","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"105","spread":null},{"groupId":"OG003","value":"33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"133","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"105","spread":null},{"groupId":"OG003","value":"27","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"119","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Opsonophagocytic Activity (OPA) Against Pneumococcal Cross-reactive Serotypes 6A and 19A ≥ the Cut-off","description":"The cut-off for the assay was 8.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"82","spread":null},{"groupId":"OG001","value":"30","spread":null},{"groupId":"OG002","value":"63","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"127","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"97","spread":null},{"groupId":"OG003","value":"32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"11","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"74","spread":null},{"groupId":"OG003","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Antibody Concentrations Against Protein D (Anti-PD) ≥ the Cut-off","description":"The cut-off for the assay was 100 ELISA units per milliliter (EL.U/mL).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"131","spread":null},{"groupId":"OG001","value":"28","spread":null},{"groupId":"OG002","value":"117","spread":null},{"groupId":"OG003","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"23","spread":null},{"groupId":"OG002","value":"125","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]}]},{"type":"SECONDARY","title":"Anti-diphtheria (Anti-DT) and Anti-tetanus Toxoids (Anti-TT) Antibody Concentrations","description":"Seroprotection status, defined as anti-diphtheria toxoid or anti-tetanus toxoid antibody concentrations ≥ 0.1 international units per milliliter (IU/mL).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.258","spread":null},{"groupId":"OG001","value":"0.17","spread":null},{"groupId":"OG002","value":"0.188","spread":null},{"groupId":"OG003","value":"0.126","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.829","spread":null},{"groupId":"OG001","value":"4.768","spread":null},{"groupId":"OG002","value":"8.463","spread":null},{"groupId":"OG003","value":"4.876","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.735","spread":null},{"groupId":"OG001","value":"0.455","spread":null},{"groupId":"OG002","value":"0.568","spread":null},{"groupId":"OG003","value":"0.525","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.979","spread":null},{"groupId":"OG001","value":"9.703","spread":null},{"groupId":"OG002","value":"12.171","spread":null},{"groupId":"OG003","value":"6.719","spread":null}]}]}]},{"type":"SECONDARY","title":"Anti-polyribosyl-ribitol-phosphate (Anti-PRP) Antibody Concentrations","description":"Seroprotection status, defined as anti-PRP antibody concentrations ≥ 0.15 μg/mL and ≥ 1.0 μg/mL.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.335","spread":null},{"groupId":"OG001","value":"6.433","spread":null},{"groupId":"OG002","value":"1.03","spread":null},{"groupId":"OG003","value":"0.894","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"106.004","spread":null},{"groupId":"OG001","value":"89.376","spread":null},{"groupId":"OG002","value":"53.386","spread":null},{"groupId":"OG003","value":"33.656","spread":null}]}]}]},{"type":"SECONDARY","title":"Anti-Bordetella Pertussis (BPT) Antibody Concentrations","description":"Seropositivity status, defined as anti-BPT antibody concentrations ≥ 15 EL.U/mL.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.88","spread":null},{"groupId":"OG001","value":"12.46","spread":null},{"groupId":"OG002","value":"9.54","spread":null},{"groupId":"OG003","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"139.51","spread":null},{"groupId":"OG001","value":"133.45","spread":null},{"groupId":"OG002","value":"121.73","spread":null},{"groupId":"OG003","value":"121.76","spread":null}]}]}]},{"type":"SECONDARY","title":"Anti-hepatitis B Surface Antigen (HBs) Antibody Concentrations","description":"Seroprotection status, defined as anti-HBs antibody concentrations ≥ 10 milli international units per milliliter (mIU/mL).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30","spread":null},{"groupId":"OG001","value":"23.4","spread":null},{"groupId":"OG002","value":"97.9","spread":null},{"groupId":"OG003","value":"113","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1220.5","spread":null},{"groupId":"OG001","value":"1098.1","spread":null},{"groupId":"OG002","value":"4428.7","spread":null},{"groupId":"OG003","value":"3188.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Anti-polio Type 1, 2 and 3 Antibody Titers","description":"Seroprotection status, defined as anti-polio type 1, anti-polio type 2 and anti-polio type 3 antibody titers ≥ 8.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"329.1","spread":null},{"groupId":"OG001","value":"269","spread":null},{"groupId":"OG002","value":"46.5","spread":null},{"groupId":"OG003","value":"51.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"854.6","spread":null},{"groupId":"OG001","value":"426.9","spread":null},{"groupId":"OG002","value":"932.5","spread":null},{"groupId":"OG003","value":"727.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"222.6","spread":null},{"groupId":"OG001","value":"210.4","spread":null},{"groupId":"OG002","value":"50.2","spread":null},{"groupId":"OG003","value":"60.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"716.9","spread":null},{"groupId":"OG001","value":"689.1","spread":null},{"groupId":"OG002","value":"1195.7","spread":null},{"groupId":"OG003","value":"1206.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"102.2","spread":null},{"groupId":"OG001","value":"38.4","spread":null},{"groupId":"OG002","value":"51.8","spread":null},{"groupId":"OG003","value":"71.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"232.7","spread":null},{"groupId":"OG001","value":"190.4","spread":null},{"groupId":"OG002","value":"1464.2","spread":null},{"groupId":"OG003","value":"1346.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-Bordetella Pertussis (BPT) With Concentrations ≥ the Cut-off","description":"The cut-off for the assay was 15 EL.U/mL.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null},{"groupId":"OG001","value":"10","spread":null},{"groupId":"OG002","value":"12","spread":null},{"groupId":"OG003","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"59","spread":null},{"groupId":"OG003","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-diphtheria (Anti-DT) and Anti-tetanus Toxoids (Anti-TT) Antibody Concentrations ≥ the Cut-off","description":"The cut-off for the assay was 0.1 milli-international units per milliliter (mIU/mL).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null},{"groupId":"OG001","value":"18","spread":null},{"groupId":"OG002","value":"49","spread":null},{"groupId":"OG003","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"59","spread":null},{"groupId":"OG003","value":"24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"24","spread":null},{"groupId":"OG002","value":"60","spread":null},{"groupId":"OG003","value":"23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"58","spread":null},{"groupId":"OG003","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-polyribosyl-ribitol Phosphate (Anti-PRP) Antibody Concentration ≥ the Cut-off","description":"The cut-off for the assay was 0.15 μg/mL.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"58","spread":null},{"groupId":"OG003","value":"23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"59","spread":null},{"groupId":"OG003","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-PRP Antibody Concentration ≥ the Cut-off","description":"The cut-off for the assay was 1.0 μg/mL.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null},{"groupId":"OG001","value":"22","spread":null},{"groupId":"OG002","value":"32","spread":null},{"groupId":"OG003","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"57","spread":null},{"groupId":"OG003","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-hepatitis B Surface Antigen (HBs) Antibody Concentrations ≥ the Cut-off","description":"The cut-off for the assay was 10 mIU/mL.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53","spread":null},{"groupId":"OG001","value":"13","spread":null},{"groupId":"OG002","value":"63","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"19","spread":null},{"groupId":"OG002","value":"62","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-polio Type 1, 2 and 3 (Anti-Polio 1, 2 and 3) Antibody Titers ≥ the Cut-off","description":"The cut-off for the assay was 8.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64","spread":null},{"groupId":"OG001","value":"19","spread":null},{"groupId":"OG002","value":"56","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"19","spread":null},{"groupId":"OG002","value":"63","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null},{"groupId":"OG001","value":"21","spread":null},{"groupId":"OG002","value":"59","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null},{"groupId":"OG001","value":"21","spread":null},{"groupId":"OG002","value":"63","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"17","spread":null},{"groupId":"OG002","value":"61","spread":null},{"groupId":"OG003","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66","spread":null},{"groupId":"OG001","value":"20","spread":null},{"groupId":"OG002","value":"63","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Vaccine Response to Anti-Bordetella Pertussis (BPT)","description":"Vaccine response for anti-BPT, defined as the appearance of antibodies in subjects seronegative at pre-vaccination, or at least 2-fold increase of pre-vaccination antibody concentrations in those who were initially seropositive at pre-vaccination.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null},{"groupId":"OG001","value":"15","spread":null},{"groupId":"OG002","value":"48","spread":null},{"groupId":"OG003","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"8","spread":null},{"groupId":"OG002","value":"11","spread":null},{"groupId":"OG003","value":"7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":280},"commonTop":["Pain","Irritability","Pyrexia","Erythema","Somnolence"]}}}